XML 39 R22.htm IDEA: XBRL DOCUMENT
v3.25.1

Stock-Based Compensation | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract] |
Stock-Based Compensation | Stock-Based Compensation 2018 Stock Plan On November 27, 2018, the Legacy Xos’s board of directors and stockholders adopted the 2018 Stock Plan. There are no shares available for issuance under the 2018 Stock Plan, however, the 2018 Stock Plan continues to govern the terms and conditions of the outstanding awards granted under the 2018 Stock Plan. As of December 31, 2024 there were 1,669 Options outstanding under the 2018 Stock Plan. The amount and terms of Option grants were determined by the board of dir ectors of Legacy Xos. The Options granted under the 2018 Stock Plan generally expire within 10 years from the date of grant and generally vest over four years, at the rate of 25% on the fir st anniversary of the date of grant and ratably on a monthly basis over the remaining 36-month pe riod thereafter based on continued service. Stock option activity during the year ended December 31, 2024 consisted of the following:
| Options |  | Weighted Average Fair Value |  | Weighted Average Exercise Price |  | Weighted Average Remaining Years |  | Intrinsic Value
December 31, 2023 — Options outstanding | 22,512 |  |  | $ | 0.40 |  |  | $ | 0.51 |  |  | 0.55 |  | $ | 168,194 |
Granted | — |  |  | — |  |  | — |  |  |  |  |
Exercised | (20,843) |  |  | 0.39 |  |  | 0.50 |  |  |  |  | 141,766 |
Forfeited | — |  |  | — |  |  | — |  |  |  |  | — |
December 31, 2024 — Options outstanding | 1,669 |  |  | $ | 0.54 |  |  | $ | 0.60 |  |  | 4.80 |  | $ | 4,404 |
December 31, 2024 — Options vested and exercisable | 1,669 |  |  | $ | 0.54 |  |  | $ | 0.60 |  |  | 4.80 |  | $ | 4,404 |
Aggregate intrinsic value represents the difference between the exercise price of the options and the fair value of the Company’s Common Stock. The aggregate intrinsic value of options exercised during the years ended December 31, 2024 and 2023 were approximately $0.1 million and $0.2 million, re spectively. The Company estimates the grant date fair value of options utilizing the Black-Scholes option pricing model, which is dependent upon several varia bles, including expected option term, expected volatility of the Company's share price over the expected term, expected risk-free rate and expected dividend yield rate. There were no option grants during the years ended December 31, 2024 and 2023. 2021 Equity Plan On August 19, 2021 the Company’s stockholders approved the 2021 Equity Plan, which was ratified by the Company’s board of directors on August 20, 2021. The 2021 Equity Plan provides for the grant of incentive stock options (“ISOs”), within the meaning of Section 422 of the Code to employees, including employees of any parent or subsidiary, and for the grant of non-statutory stock options (“NSOs”), stock appreciation rights, restricted stock awards, RSUs, performance awards and other forms of awards to employees, directors and consultants, including employees and consultants of Xos’s affiliates. On June 24, 2024, the Company’s stockholders approved the Xos, Inc. Amended and Restated 2021 Equity Incentive Plan (the “A&R 2021 Equity Plan”) to increase the aggregate number of shares of Common Stock reserved for issuance under the 2021 Equity Plan by 1,180,819 shares. As of December 31, 2024, there w ere 536,139 shares of Common Stock available for issuance under the A&R 2021 Equity Plan. RSU activity during the year ended December 31, 2024 consisted of the following:
| RSUs |  | Weighted Average Grant Date Fair Value |  | Aggregate Fair Value
December 31, 2023 — RSU outstanding | 603,040 |  | $ | 18.97 |  |  | $ | 4,819,138 |
Granted | 1,587,213 |  |  | 6.64 |  |  | 8,936,180 |
Vested | (471,948) |  |  | 15.77 |  |  | 3,526,706 |
Forfeited | (187,824) |  |  | 10.64 |  |  | 1,004,728 |
December 31, 2024 — RSU outstanding | 1,530,481 |  |  | $ | 8.14 |  |  | $ | 4,961,551 |
The Company recognized stock-based compensation expense (including Earn-out RSUs) in the consolidated statements of operations and comprehensive loss for the years ended December 31, 2024 and 2023 totaling approximate ly $7.7 million and $7.9 million, respectively, which consisted of the following (in thousands):
|  | December 31, 2024 |  | December 31, 2023
Cost of goods sold |  | $ | 354 |  |  | $ | 396 |
Research and development |  | 1,435 |  |  | 1,824 |
Sales and marketing |  | 738 |  |  | 966 |
General and administrative |  | 5,183 |  |  | 4,720 |
Total |  | $ | 7,710 |  |  | $ | 7,906 |
We allocate stock-based compensation expense to cost of goods sold, research and development expense, sales and marketing expense and general and administrative expense, based on the roles of the applicable recipients of such stock-based compensation. The unamortized stock-based compensation expense was $10.1 million as of December 31, 2024, and weighted average remaining amortization period as of December 31, 2024 was 1.91 years. The aggregate fair value of RSUs that vested was $3.5 million during the year ended December 31, 2024.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration